DNA methylation aging clocks: challenges and recommendations

Christopher G. Bell(Queen Mary University of London), Robert Lowe(Queen Mary University of London), Peter D. Adams(Sanford Burnham Prebys Medical Discovery Institute), Andrea Baccarelli(Columbia University Irving Medical Center), Stephan Beck(Cancer Research UK), Jordana T. Bell(King's College London), Brock C. Christensen(Dartmouth College), Vadim N. Gladyshev(Brigham and Women's Hospital), Bastiaan T. Heijmans(Leiden University Medical Center), Steve Horvath(University of California, Los Angeles), Trey Ideker(University of San Diego), Jean‐Pierre J. Issa(Temple University), Karl T. Kelsey(Brown University), Riccardo E. Marioni(Edinburgh Cancer Research), Wolf Reik(Babraham Institute), Caroline L. Relton(Bristol City Council), Leonard C. Schalkwyk(University of Essex), Andrew E. Teschendorff(Chinese Academy of Sciences), Wolfgang Wagner(RWTH Aachen University), Kang Zhang(Macau University of Science and Technology), Vardhman K. Rakyan(Queen Mary University of London)
Genome biology
November 25, 2019
Cited by 1,093Open Access
Full Text

Abstract

Epigenetic clocks comprise a set of CpG sites whose DNA methylation levels measure subject age. These clocks are acknowledged as a highly accurate molecular correlate of chronological age in humans and other vertebrates. Also, extensive research is aimed at their potential to quantify biological aging rates and test longevity or rejuvenating interventions. Here, we discuss key challenges to understand clock mechanisms and biomarker utility. This requires dissecting the drivers and regulators of age-related changes in single-cell, tissue- and disease-specific models, as well as exploring other epigenomic marks, longitudinal and diverse population studies, and non-human models. We also highlight important ethical issues in forensic age determination and predicting the trajectory of biological aging in an individual.


Related Papers

No related papers found

Powered by citation graph analysis